Display Settings:

Format

Send to:

Choose Destination
Med Monatsschr Pharm. 2013 May;36(5):191-4.

[Depression: what do we know today and where does the journey lead?].

[Article in German]

Author information

  • egid.strehl@klinikum.uni-freiburg.de

Abstract

Personalized pharmacotherapy based on pharmacogenetic data tends to improve therapeutic outcome in neurological and mental diseases including depression. Combination of available data from genomics, proteomics, metabolomics, neuroimaging and neuroendocrinology would lead to a successful personalized therapy of depression in the near future, which is based on genotypes and biomarkers. Close collaboration between basic and clinical research is indispensable. Different research approaches for a personalized therapy of depression were introduced within the framework of the Robert Pfleger research award 2012.

PMID:
23758029
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk